Assenagon Asset Management
ACHN

Assenagon Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Assenagon Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-234,476
Closed -$373K – 1199
2018
Q4 		$373K Sell
234,476
-1,151,384
-83% -$3.25M ﹤0.01% 881
2018
Q3 		$5.1M Buy
+1,385,860
New +$4.13M 0.05% 298
2018
Q2 		– Sell
-1,099,033
Closed -$4.08M – 635
2018
Q1 		$4.08M Buy
+1,099,033
New +$3.6M 0.05% 256

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assenagon Asset Management's ACHN Position: Q1 2019 in Review

Assenagon Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2019, closing a stake of 234,476 shares — an estimated $373K sold.

Assenagon Asset Management first reported a position in ACHN in Q1 2018 and held it in 3 quarters. The position peaked at $5.1M in Q3 2018. 110 funds tracked by Wall St. Rank hold ACHN as of Q1 2019.

  • Assenagon Asset Management reported no remaining Achillion Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 234,476 Achillion Pharmaceuticals shares in Q1 2019, an estimated $373K.
  • Assenagon Asset Management first reported a position in Achillion Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Assenagon Asset Management's Achillion Pharmaceuticals position peaked at $5.1M in Q3 2018.
  • 110 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2019.

Based on Assenagon Asset Management's 13F filing for Q1 2019, filed 26 Apr 2019.